Objective Control of acromegaly may ameliorate blood pres- sure (BP) in hypertensive (HT) patients. We evaluated the impact of acromegaly control on BP values of normotensive (NT) acromegalics. Design Retrospective cohort study. Patients Fifty-eight na€ıve patients with acromegaly (39 F; age range, 30–69 years), including 28 NT and 30 HT subjects, par- ticipated in the study. Measurements Blood pressure was measured by clinical mea- surement and 24-h ambulatory monitoring at diagnosis and after 24 months of medical therapy for acromegaly. Results Acromegaly was controlled by medical therapy in 15 NT and 17 HT patients at 24 months. In the NT group, systolic (SBP) or diastolic (DBP) BP significantly increased (all P < 0 005) when acromegaly was uncontrolled, but did not change when the disease was controlled. Changes in SBP and DBP were also significantly different between uncontrolled and controlled NT patients. At 24 months, clinical hypertension was detected only in uncontrolled NT patients (46% vs 0%, P < 0 001), whereas ambulatory hypertension was found in 38% of uncontrolled and in 7% of controlled NT subjects (P = 0 035). In the HT group, ambulatory SBP increased in patients with uncontrolled acromegaly (24-h SBP P = 0 046, day SBP P = 0 005, night SBP P = 0 005), whereas ambulatory DBP decreased in subjects with controlled disease (24-h DBP P = 0 008, day DBP P = 0 026). Conclusions Control of acromegaly has a beneficial effect on BP regulation either in HT or NT subjects; in the latter, it may prevent progression towards hypertension.

The beneficial effect of acromegaly control on blood pressure values in normotensive patients

URBANI, CLAUDIO;SCATTINA, ILARIA;DI BELLO, VITANTONIO;MARTINO, ENIO;BOGAZZI, FAUSTO
2014-01-01

Abstract

Objective Control of acromegaly may ameliorate blood pres- sure (BP) in hypertensive (HT) patients. We evaluated the impact of acromegaly control on BP values of normotensive (NT) acromegalics. Design Retrospective cohort study. Patients Fifty-eight na€ıve patients with acromegaly (39 F; age range, 30–69 years), including 28 NT and 30 HT subjects, par- ticipated in the study. Measurements Blood pressure was measured by clinical mea- surement and 24-h ambulatory monitoring at diagnosis and after 24 months of medical therapy for acromegaly. Results Acromegaly was controlled by medical therapy in 15 NT and 17 HT patients at 24 months. In the NT group, systolic (SBP) or diastolic (DBP) BP significantly increased (all P < 0 005) when acromegaly was uncontrolled, but did not change when the disease was controlled. Changes in SBP and DBP were also significantly different between uncontrolled and controlled NT patients. At 24 months, clinical hypertension was detected only in uncontrolled NT patients (46% vs 0%, P < 0 001), whereas ambulatory hypertension was found in 38% of uncontrolled and in 7% of controlled NT subjects (P = 0 035). In the HT group, ambulatory SBP increased in patients with uncontrolled acromegaly (24-h SBP P = 0 046, day SBP P = 0 005, night SBP P = 0 005), whereas ambulatory DBP decreased in subjects with controlled disease (24-h DBP P = 0 008, day DBP P = 0 026). Conclusions Control of acromegaly has a beneficial effect on BP regulation either in HT or NT subjects; in the latter, it may prevent progression towards hypertension.
2014
Chiara, Sardella; Urbani, Claudio; Martina, Lombardi; Alessandro, Nuzzo; Luca, Manetti; Isabella, Lupi; Giuseppe, Rossi; Simone Del, Sarto; Scattina, Ilaria; DI BELLO, Vitantonio; Martino, Enio; Bogazzi, Fausto
File in questo prodotto:
File Dimensione Formato  
Sardella_et_al-2014-Clinical_Endocrinology.pdf

solo utenti autorizzati

Tipologia: Versione finale editoriale
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 85.78 kB
Formato Adobe PDF
85.78 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11568/409491
Citazioni
  • ???jsp.display-item.citation.pmc??? 6
  • Scopus 19
  • ???jsp.display-item.citation.isi??? 16
social impact